chr19-16479219-C-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_145046.5(CALR3):​c.1067G>T​(p.Arg356Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00131 in 1,614,080 control chromosomes in the GnomAD database, including 28 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R356C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0071 ( 13 hom., cov: 31)
Exomes 𝑓: 0.00071 ( 15 hom. )

Consequence

CALR3
NM_145046.5 missense

Scores

5
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.0740
Variant links:
Genes affected
CALR3 (HGNC:20407): (calreticulin 3) The protein encoded by this gene belongs to the calreticulin family, members of which are calcium-binding chaperones localized mainly in the endoplasmic reticulum. This protein is also localized to the endoplasmic reticulum lumen, however, its capacity for calcium-binding may be absent or much lower than other family members. This gene is specifically expressed in the testis, and may be required for sperm fertility. Mutation in this gene has been associated with familial hypertrophic cardiomyopathy. [provided by RefSeq, Dec 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0045229197).
BP6
Variant 19-16479219-C-A is Benign according to our data. Variant chr19-16479219-C-A is described in ClinVar as [Benign]. Clinvar id is 416237.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-16479219-C-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00712 (1083/152196) while in subpopulation AFR AF= 0.0246 (1020/41540). AF 95% confidence interval is 0.0233. There are 13 homozygotes in gnomad4. There are 487 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1083 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CALR3NM_145046.5 linkuse as main transcriptc.1067G>T p.Arg356Leu missense_variant 9/9 ENST00000269881.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CALR3ENST00000269881.8 linkuse as main transcriptc.1067G>T p.Arg356Leu missense_variant 9/91 NM_145046.5 P1

Frequencies

GnomAD3 genomes
AF:
0.00711
AC:
1081
AN:
152078
Hom.:
13
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0246
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00282
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.00481
GnomAD3 exomes
AF:
0.00176
AC:
443
AN:
251474
Hom.:
7
AF XY:
0.00147
AC XY:
200
AN XY:
135914
show subpopulations
Gnomad AFR exome
AF:
0.0231
Gnomad AMR exome
AF:
0.00139
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000653
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000791
Gnomad OTH exome
AF:
0.00130
GnomAD4 exome
AF:
0.000711
AC:
1039
AN:
1461884
Hom.:
15
Cov.:
31
AF XY:
0.000635
AC XY:
462
AN XY:
727246
show subpopulations
Gnomad4 AFR exome
AF:
0.0235
Gnomad4 AMR exome
AF:
0.00152
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000696
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000513
Gnomad4 OTH exome
AF:
0.00192
GnomAD4 genome
AF:
0.00712
AC:
1083
AN:
152196
Hom.:
13
Cov.:
31
AF XY:
0.00655
AC XY:
487
AN XY:
74406
show subpopulations
Gnomad4 AFR
AF:
0.0246
Gnomad4 AMR
AF:
0.00282
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000147
Gnomad4 OTH
AF:
0.00476
Alfa
AF:
0.000988
Hom.:
2
Bravo
AF:
0.00818
ESP6500AA
AF:
0.0238
AC:
105
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00221
AC:
268
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Hypertrophic cardiomyopathy 19 Benign:2
Benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, University Medical Center UtrechtApr 11, 2016- -
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpAug 16, 2017Variant summary: The CALR3 c.1067G>T (p.Arg356Leu) variant involves the alteration of a non-conserved nucleotide. 2/4 in silico tools predict a benign outcome for this variant (SNPsandGO not captured due to low reliability index). This variant was found in 268/121408 control chromosomes (6 homozygotes) from ExAC, predominantly observed in the African subpopulation at a frequency of 0.024025 (250/10406). This frequency is about 961 times the estimated maximal expected allele frequency of a pathogenic CALR3 variant (0.000025), suggesting this is likely a benign polymorphism found primarily in the populations of African origin. In addition, one clinical diagnostic laboratory in ClinVar has classified this variant as benign. To our knowledge, this variant has not been reported in affected individuals via publications, nor has it been evaluated for functional impact by in vivo/vitro studies. Taken together, this variant is classified as benign. -
Primary dilated cardiomyopathy Benign:1
Benign, criteria provided, single submitterclinical testingCenter for Advanced Laboratory Medicine, UC San Diego Health, University of California San DiegoFeb 07, 2018- -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJan 10, 2013General population or subpopulation frequency is too high to be a pathogenic mutation based on disease/syndrome prevalence and penetrance -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
13
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.44
T
Eigen
Benign
-0.90
Eigen_PC
Benign
-0.95
FATHMM_MKL
Benign
0.041
N
LIST_S2
Benign
0.74
T
MetaRNN
Benign
0.0045
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.3
L
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.23
T
PROVEAN
Uncertain
-3.7
D
REVEL
Benign
0.055
Sift
Uncertain
0.016
D
Sift4G
Uncertain
0.032
D
Polyphen
0.36
B
Vest4
0.34
MVP
0.30
MPC
0.31
ClinPred
0.021
T
GERP RS
-1.5
Varity_R
0.15
gMVP
0.68

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs140290452; hg19: chr19-16590030; COSMIC: COSV54169033; COSMIC: COSV54169033; API